Background and objective: Cirrhosis affects hundreds of millions of patients all around the world. Vitamin D deficiency is frequently observed in chronic hepatic disease. Vitamin D level may be an important survival marker in advanced liver cirrhosis. Material and Methods: The study is a sectional one of the descriptive-analytical type, where 90 of the patients with hepatic cirrhoses were selected with census sampling method. In all the cirrhotic patients, for diagnosis in clinical findings, the serological marker, autoantibodies were stable; biochemical endoscopy and imaging were the histological evidence and examinations and were then analyzed by SPSS version 22 software. Results: Based on the study, from the aspect of Child-Pugh classification, the highest vitamin D levels had the highest value in Child-Pugh class A with a frequency of 13 (43%) in the form of insufficiency, and had the highest value in ChildPugh class B and C in the form of slight deficiency. Conclusion: It was specified based on the results obtained from the research that different vitamin D levels and liver failure severity have a significant relationship with each other (p < 0.05) in patients suffering from hepatic cirrhosis, such that the serum vitamin D level decreases as liver failure severity increases.
patic disease. Vitamin D level may be an important survival marker in advanced liver cirrhosis [1] . The main source of the vitamin in humans is contact with the skin exposed to sunlight, where vitamin D hydroxylation occurs in the liver in the form of 25(OH)VIT D3 using enzymes like cytochrome P450 present in mitochondria and microsomes, and hydroxylation is in the form of 1.25(OH)VIT D3 in the kidney. Different factors are involved in vitamin D deficiency, one of which is hepatic 25-hydroxylation disorder. Vitamin D supplement level can best be measured by measuring 25(OH)VIT D3 levels [2] . Besides its role in calcium and phosphorus homeostasis, it plays an important role in body immune system adjustment in the form of antimicrobial peptide induction, innate immune response suppression, cytokine induction, and T helper 2 [3] .
In a series of studies conducted before, the relationship between the severity of some chronic hepatic diseases and vitamin D deficiency value has been specified. In Arteh J's study, vitamin D deficiency prevalence in 112 hepatic cirrhosis patients visiting a clinic was 92%, at least around one third of whom suffer from intense deficiency (p < 0.05) [4] . Caroline S's study demonstrated a significant relationship between vitamin D low level and mortality in chronic hepatic patients based on the severity of cirrhosis hepatic disease based on Child-Pugh classification (p < 0.012). Vitamin D serum level was specified as an important mortality factor in this cohort study (p = 0.012) [5] . Therefore, in view of the high prevalence of hepatic cirrhosis and its mortality as well as the high prevalence of vitamin D deficiency in the public and its higher prevalence in patients with hepatic cirrhosis and the role vitamin D plays in osteoporosis, bone fracture and muscle strength decrease and inflammatory response disorder and malignity and even mortality as well as better response to treatment of some patients with hepatic cirrhosis, convinced us to consider the factors disturbing the above studies such as multifactorial causes of vitamin D deficiency and also consider as far as possible all causes of hepatic cirrhosis and specify the hepatic disease severity to obtain serum vitamin D level and hepatic cirrhosis severity so that vitamin D level range can be determined to some extent at any level of hepatic cirrhosis severity, and it can be determined through this study how much vitamin D deficiency there is at each hepatic disease severity if the disturbing factors are removed, so that the required supplements are prescribed with the recommended dosage based on hepatic disease severity, and with prescription of the dosages of vitamin D determined based on disease severity, effective steps are taken in increasing muscle strength and treating inflammatory response disorder and malignity and even mortality as well as better response to treatment of some patients with hepatic cirrhosis and preventing from complications.
Objectives of the Study
• Specification of the relationship between serum vitamin D level and hepatic cirrhosis severity in cirrhotic patients based on Child-Pugh classification.
• Specification of the relationship between serum vitamin D level and hepatic cirrhosis severity in cirrhotic patients based on MELD score.
• Specification of the relationship between serum vitamin D and serum albumin levels in hepatic cirrhotic patients.
• Specification of the relationship between serum vitamin D and hepatic enzyme levels in hepatic cirrhotic patients.
• Specification of the relationship between serum vitamin D and Plt levels in hepatic cirrhotic patients.
• Specification of the relationship between serum vitamin D and GFR levels in hepatic cirrhotic patients.
• Specification of the relationship between serum vitamin D and serum PTH, calcium, and phosphorus levels in hepatic cirrhotic patients.
• Specification of the relationship between serum vitamin D level and age, gender, and BMI in hepatic cirrhotic patients.
• Specification of the relationship between serum vitamin D level and cirrhosis cause in hepatic cirrhotic patients.
• Specification of the relationship between serum vitamin D level and visiting season in hepatic cirrhotic patients.
Material and Methods
The study is a sectional one of the descriptive-analytical type and Information on ethics committee approval and informed consent. In this cirrhotic study, for diagnosis in clinical findings, the serological marker of Hepatitis B and C, Hepatitis B virus DNA, and Hepatitis C virus RNA measurement using polymerase chain reaction method, autoantibodies (anti-cell antibody, anti-smooth muscle antibody) were stable; biochemical (such as iron studies, ceruloplasmin, and copper urine), endoscopy, imaging (such as abdominal sonography) were the histological evidence and examinations (liver biopsy examination). Diagnosis of cirrhosis was based on liver biopsy or clinical evidence or deterministic biochemistry of liver failure and/or portal hypertension [6] . 90 of the hepatic cirrhotic patients visiting and hospitalized at Towhid Hospital, Sanandaj were selected using the sampling method, in 2015-2016. During data collection, the BMIs, ages, genders, and visiting seasons and whether their locations are urban or rural was specified for all of the patients. Diagnosis in clinical and laboratory findings and the serological marker of Hepatitis B and C, Hepatitis B virus DNA, and Hepatitis C virus RNA measurement using polymerase chain reaction method, autoantibodies (anti-cell antibody, anti-smooth muscle antibody) biochemical (such as iron studies, ceruloplasmin, and copper urine), endoscopy and imaging were the histological evidence and examinations (liver biopsy examination). Diagnosis of cirrhosis was based on liver biopsy or clinical evidence or deterministic biochemistry of liver failure and/or portal hypertension. Blood sample was taken after one night 10 -12 hours fasting, and sent to the unit laboratory. CBC was performed by Cell Counter machine (K*21 Sysx), and ALT, AST, ALK, Ph, Ca, Cr, P, PTT, T, INR, and Alb, Bil T were performed by autoanalyzer machine and Japanese Prestige model biochemistry. Serum Ca Level was corrected with Alb density. PTH was measured by ELISA kit from American company Biomedical and 25(OH)VIT D3 by chemiluminescent kit from German company ROSH. The tests were performed using available commercial kits based on the instructions provided by the producing factory. Abdominal sonography (Hitachi EUB-405, machine equipped with 3.5 megahertz convex probe) was used for examination of the liver, spleen, ascites, and portal vein in all the patients by a radiology specialist. The patients were classified into three groups using ChildPugh: Class A (disease compensated well, scores 5 -6) Class B (significant functional compromise, scores 7 -9) Class C (disease decompensated, scores 10 -15). MELD was measured.
In this research, using Chi Square statistical analyses for the categorical variables and Independent T-test for the continuous variables, Logistic Regression Test was used for specification of the predictive variables in occurrence of he- The study was approved by the Ege University Ethical Committee. Written informed consent was obtained from patients who participated in this study.
Results

Analytical Results
The results of Chi Square statistical test did not demonstrate a significant relationship between Alkp, Alb, Plt, and Ca (p > 0.05); but statistically significant relationships were observed between Child-Pugh classification, ALT, INR, AST, Ph, PTH, Season, Causes of disease, Location, and Gender (p < 0.05) Table 1 . The results on that basis, the highest vitamin D levels based on Child-Pugh had the highest value in insufficient form in Child class A with a frequency of 13 (43%) and the highest value in mild deficiency form in Child class B and C Table 2. For ALT enzyme, it had the highest value in mild deficiency form with a frequency of 20 (62%) for normal patients and 26 (44%) for abnormal ones; for gender, it had the highest value in mild deficiency form with a frequency of 24 (43%) for the men and 22 (62%) for the women; for AST enzyme serum level, it had the highest value in mild deficiency form with a frequency of 28 (51%) for normal patients and 18 (50%) for abnormal ones; for PH value, it had the highest value in mild deficiency form with a frequency of 39 (51%) for normal patients and 7 (50%) for abnormal ones; for PTH hormone, it had the highest value in mild deficiency form with a frequency of 28 (45%) for normal patients and 18 (64%) for abnormal ones; for the patients' visiting seasons, it had the highest value in mild deficiency and insufficient value form with a frequency of 5 (35%) for Spring, in mild deficiency form with a frequency of 22 (57%) for Summer, in mild deficiency form with a frequency of 12 (66%) for Fall, and in moderate deficiency form with a frequency of 8 (40%) for Winter; for cause of the disease Table 3 . The results shows that the highest values respectively concern Hepatitis B with a frequency of 21 (53%) in mild deficiency form, Hepatitis C with a frequency of 4 (44%) in moderate deficiency form, Autoimmune H with a frequency of 3 (50%) in mild deficiency form, Cryptogenic with a frequency of 10 (52%) in mild deficiency form, Thrombosis with a frequency of 2 (33%) in insufficient, mild deficiency, and moderate deficiency equal forms, Cardiac with a frequency of 5 (62%) in mild deficiency form, and PSC and Wilson with frequencies of 1 (100%) in moderate deficiency form; for location, it was in mild deficiency form with a frequency of 32 (57%) for the patients from urban locations and in mild deficiency form with a frequency of 14 (41%) for those from rural locations; as for INR, it was in mild deficiency form with a frequency of 11 (39%) for normal patients and in mild deficiency form with a frequency of 35 (56%) for abnormal patients Table 4 and Table 5 . Based on the results obtained from Anova test, since the observed significance level is less than 0.05 at 95 percent confidence level, there is statistically significant difference between age, BMI, and MELD, BilT, and GFR criteria and different vitamin D levels (p < 0.05); on that basis, the highest vitamin D value has the lowest value for the patients' ages with 66 and 57 average years of age, the highest value for BMI with 23 kg/m 2 in average and the lowest with 17 kg/m 2 , the highest value for MELD score with an average of 17 and the lowest with 16, the highest value for BILT with 4 mg/dl in average and the lowest with 2 mg/dl, and the highest value for GFR with an average of 59 ml/min and the lowest value with 40 ml/min.
Based on the results obtained from logistic regression, it was observed that the Wald test statistic is 2 for Alb, and with p-value = 0.86 > 0.05, the factor is not effective on the patients' hepatic cirrhosis severity in this study, and the variable is not considered as a prognostic factor, which can be caused by albumin recep- 
Discussion
The results showed that a significant relationship was observed between Child- [11] . Consequently, vitamin D deficiency has been associated with increased circulating MMP2.9, a situation that can be corrected with vitamin D supplementation [12] . Other effects of vitamin D include suppression of proliferation of fibroblasts and increased collagen production [13] . Vitamin D supplementation may have antifibrotic effects in patients [14] . Then, vitamin D levels should be monitoring and deficient patients should be treated with vitamin D supplementation [15] . Some studies demonstrated an association between vitamin D status and mortality amongst which liver diseases as a cause of death were included [16] [17].
Limitations and Suggestions for Future Studies
The limitation of this study concerned with the people who were examined as statistical population. It is suggested that the research be comparatively conducted in other hospitals on patients suffering from hepatic cirrhosis and determination required supplements are prescribed with the recommended dosage based on hepatic disease severity.
